......................................... Received: 11-02-14 Accepted: 21-02-14 Abstract In a normal human liver 5% of its mass consists of lipids. When deposition of fat increases, the terms most often used are fatty liver or steatosis. This includes non-alcoholic fatty liver disease whose acronym is NAFLD and alcoholic liver disease (ALD). A liver biopsy is still considered to be the gold sta...

BACKGROUND There are insufficient data available on utilization and health care costs of non-alcoholic fatty liver disease. The cost data for different health conditions and services is a major gap in Iranian health system. So this study is the primary or first step towards filling this gap. OBJECTIVES This study aims to estimate the diagnosis and treatment costs of Non-alcoholic Fatty Liver....

Since non-alcoholic fatty liver disease (NAFLD) was first described in children in the early 1980s by Moran and colleagues, a number of case series have been reported. Awareness of the disease has been growing among healthcare providers in the last few years, and nowadays NAFLD represents the most common cause of chronic liver disease in youth. Its growing prevalence in westernised countries ha...

"Erratum: Diagnostic and prognostic potential of kallistatin in assessment liver parenchyma changes patients with non-alcoholic fatty disease hypertension" published on 09 Nov 2021 by Akadémiai Kiadó.

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome. Since the prevalence of obesity and consequently of the metabolic syndrome is steadily increasing, the different types of NAFLD are nowadays the most common cause of liver injury in North America. The development of NASH and fatty liver cirrhosis occurs af...